PredxBio, Inc., which leverages AI for digital pathology markets, announced the launch of company with the recent closing of a seed financing round led by Newlin Investment Company, an early-stage venture capital firm.
![](https://predxbio.com/wp-content/uploads/2022/04/LI_220404_AACR-298x300.png)
PredxBio at AACR 2022
PredxBio is ushering a new era of unbiased spatial analytics and explainable AI in precision pathology at AACR 2022 PredxBio announces that it will attend